By Professor Matthew Gwyn Law

Journal articles

Worm S; De Wit S; Weber R; Sabin C; Reiss P; El-Sadr W; D'Arminio Monforte A; Kirk O; Fontas E; Dabis F; Law MG; Lundgren JD; Friis-Moller N, 2009, 'Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).', Circulation, 119, pp. 805 - 811, http://dx.doi.org/10.1161/CIRCULATIONAHA.790857

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, 7, pp. 454 - 461

Haylen B; Yang V; Logan V; Husselbee S; Law MG; Zhou J, 2009, 'Does the presenting bladder volume at urodynamics have any diagnostic relevance?', International Urogynecology Journal, 20, pp. 319 - 324

Byakwaga H; Zhou J; Petoumenos K; Law MG; Boyd MA; Emery S; Cooper DA; Mallon PW, 2009, 'Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy', HIV Medicine, 10, pp. 143 - 151

Klug G; Wand HC; Boyd A; Law MG; Whyte S; Kaldor JM; Masters C; Collins S, 2009, 'Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster', Brain, 132, pp. 493 - 501, http://dx.doi.org/10.1093/brain/awn303

Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L, 2009, 'Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning', Addiction, 104, pp. 2049 - 2056, http://dx.doi.org/10.1111/j.1360-0443.2009.02704.x

Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576

Nguyen VT; Law MG; Dore GJ, 2009, 'Hepatitis B-related hepatocellular carcinoma: Epidemiological characteristics and disease burden', Journal of Viral Hepatitis, 16, pp. 453 - 463, http://dx.doi.org/10.1111/j.1365-2893.2009.01117.x

Wilson DP; Hoare A; Regan DG; Law MG, 2009, 'Importance of promoting HIV testing for preventing secondary transmissions: Modelling the Australian HIV epidemic among men who have sex with men', Sexual Health, 6, pp. 19 - 33, http://dx.doi.org/10.1071/SH08081

Egger S; Petoumenos K; Kamarulzaman A; Hoy JF; Sungkanuparph S; Chuah J; Falster KA; Zhou J; Law MG, 2009, 'Long term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load and time: The Asia Pacific HIV Observational Database (APHOD)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 513 - 520

Razali K; Amin J; Dore GJ; Law MG, 2009, 'Modelling and calibration of the hepatitis C epidemic in Australia', Statistical Methods in Medical Research, 18, pp. 253 - 270

Degenhardt LJ; Randall D; Hall WD; Law MG; Butler TG; Burns LA, 2009, 'Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved', Drug and Alcohol Dependence, 105, pp. 9 - 15, http://dx.doi.org/10.1016/j.drugalcdep.2009.05.021

Burns LA; Randall D; Hall WD; Law MG; Butler T; Bell JR; Degenhardt LJ; Butler , 2009, 'Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention', Addiction, 104, pp. 1363 - 1372, http://dx.doi.org/10.1111/j.1360-0443.2009.02633.x

Pujari S; Srasuebkul P; Sungkanuparph S; Lim PL; Kumarasamy N; Chuah J; Kumar R; Oka S; Choi J; Lee M; Phanuphak P; Kamarulzaman A; Lee C; Fujie Z; Ditangco R; Saphonn V; Sirisanthana T; Merati T; Law MG, 2009, 'Patient characteristics and treatment outcome associated with Protease Inhibitor (PI) use in the Asia-Pacific region', Journal of Antivirals & Antiretrovirals, 1, pp. 28 - 035, http://dx.doi.org/10.4172/jaa.1000004

Mitsuyasu RT; Merigan T; Carr AD; Zack J; Winters M; Workman C; Bloch MT; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; Mcfarlane R; Smith DE; Garsia R; Ma DD; Law MG; Murray JM; Von Kalle C; Ely JA; Patino S; Knop A; Wong P; Todd A; Haughton M; Fuery C; Marcpherson J; Symonds G; Evans L; Pond SM; Cooper DA; Cooper D; Han A, 2009, 'Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells', Nature Medicine, 15, pp. 285 - 292, http://dx.doi.org/10.1038/nm.1932

Nguyen VT; Amin J; Law MG; Dore GJ, 2009, 'Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia', Journal of Gastroenterology and Hepatology, 24, pp. 436 - 442, http://dx.doi.org/10.1111/j.1440-1746.2008.05577.x

Worm S; Sabin C; Reiss P; El-Sadr W; d'Arminio Monforte A; Pradier C; Thiebaut R; Law MG; Rickenback M; De Wit S; Lundgren JD; Friis-Moller N, 2009, 'Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.', Diabetes Care, 32, pp. 474 - 480, http://dx.doi.org/10.2337/dc08-1394

Murray JM; McDonald AM; Law MG, 2009, 'Rapidly ageing HIV epidemic among men who have sex with men in Australia', Sexual Health, 6, pp. 83 - 86, http://www.publish.csiro.au/paper/SH08063

Haylen B; Lee J; Husselbee S; Law MG; Zhou J, 2009, 'Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction', International Urogynecology Journal, 20, pp. 837 - 842

Srasuebkul P; Lim PL; Lee M; Kumarasamy N; Zhou J; Sirisanthana T; Li P; Kamarulzaman A; Oka S; Phanuphak P; Vonthanak S; Merati T; Chen Y; Sungkanuparph S; Tau G; Zhang F; Lee CK; Ditangco R; Pujari S; Choi J; Smith J; Law MG, 2009, 'Short-term clinical disease progression in hiv-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV Observational database', Clinical Infectious Diseases, 48, pp. 940 - 950, http://dx.doi.org/10.1086/597354

Gidding H; Topp L; Middleton M; Robinson K; Hellard M; McCaughan G; Maher L; Kaldor J; Dore G; Law M, 2009, 'The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997-2006', Journal of Gastroenterology and Hepatology, 24, pp. 1648 - 1654, http://dx.doi.org/10.1111/j.1440-1746.2009.05910.x

Kwon J; Iversen J; Maher L; Law M; Wilson D, 2009, 'The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: A model-based analysis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 51, pp. 462 - 469, http://dx.doi.org/10.1097/QAI.0b013e3181a2539a

Poynten IM; Millwood I; Falster M; Law MG; Andresen DN; Van Damme L; Kaldor JM, 2009, 'The safety of candidate vaginal microbicides since nonoxynol-9: A systematic review of published studies', AIDS, 23, pp. 1245 - 1254

Land S; Cunningham PH; Zhou J; Frost K; Katzenstein DA; Kantor R; Chen YMA; Oka S; Delong A; Sayer D; Dax E; Smith J; Law MG, 2009, 'TREAT Asia Quality Assessment Scheme (TAQAS) to standardise the outcome of HIV genotypic resistance testing in a group of Asian laboratories', Journal of Virological Methods, 159, pp. 185 - 193, http://dx.doi.org/10.1016/j.jviromet.2009.03.016

Srasuebkul P; Sungkanuparph S; Lim P; Law MG, 2009, 'Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection Reply', Clinical Infectious Diseases, 49, pp. 811 - U170

Wilson DP; Law MG; Grulich AE; Cooper DA; Kaldor JM, 2008, 'Relation between HIV viral load and infectiousness: a model-based analysis (vol 372, pg 314, 2008)', LANCET, 372, pp. 1808 - 1808, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000261112000022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Regan DR; Law MG; Philp DJ; Hocking JS, 2008, 'SHOULD WE BE VACCINATING BOYS AS WELL AS GIRLS WITH THE HPV VACCINE?', SEXUAL HEALTH, 5, pp. 387 - 387, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260999000033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sabin CA; Worm SW; Weber R; Reiss P; El-Sadr W; Dabis F; De Wit S; Law M; D'Arminio Monforte A; Friis-Møller N; Kirk O; Pradier C; Weller I; Phillips AN; Lundgren JD; Collins S; Rosseau F; Storfer SP; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J, 2008, 'Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: A multi-cohort collaboration', The Lancet, 371, pp. 1417 - 1426, http://dx.doi.org/10.1016/S0140-6736(08)60423-7

Nguyen VT; Law MG; Dore GJ, 2008, 'An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025', Liver International, 28, pp. 525 - 531, http://dx.doi.org/10.1111/j.1478-3231.2007.01646.x

Sabin C; Monforte A; Friis-Moller N; Weber R; El-Sadr W; Reiss P; Kirk O; Mercie P; Law MG; De Wit S; Pradier C; Phillips A; Lundgren JD, 2008, 'Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction', Clinical Infectious Diseases, 46, pp. 1101 - 1110, http://dx.doi.org/10.1086/528862

De Rose R; Fernandez CS; Smith MZ; Batten C; Alcantara S; Peut V; Rollman E; Loh L; Mason R; Wilson K; Law MG; Handley A; Kent SJ, 2008, 'Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood', PLoS Pathogens, 4

Calmy A; Carey DL; Mallon PW; Wand HC; Law MG; Cooper DA; Carr AD, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110, http://dx.doi.org/10.1111/j.1468-1293.2007.00527.x

Nguyen VT; Razali K; Amin J; Law MG; Dore GJ, 2008, 'Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries', Journal of Gastroenterology and Hepatology, 23, pp. 922 - 929, http://dx.doi.org/10.1111/j.1440-1746.2007.05065.x

Musto JA; Seed CR; Law MG; Keller AJ; Kaldor JM, 2008, 'Estimating the risk of blood donation associated with HIV risk behaviours', Transfusion Medicine, 18, pp. 49 - 54, http://dx.doi.org/10.1111/j.1365-3148.2007.00804.x

Wilson DP; Law MG; Grulich AE; Cooper DA; Kaldor JM, 2008, 'HIV transmission under highly active antiretroviral therapy Reply', Lancet, 372, pp. 1807 - 1807

Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law MG; de Witt S; Friis-Moller N; Phillips AN; Sabin C; Lundgren JD, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.', AIDS, pp. 2143 - 2153

Haylen B; Lee J; Logan V; Husselbee S; Zhou J; Law MG, 2008, 'Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction', Obstetrics and Gynecology, 111, pp. 1305 - 1312, http://dx.doi.org/10.1097/AOG.0b013e31817615b2

De Wit S; Sabin C; Weber R; Worm S; Reiss P; Cazanave C; El-Sadr W; Monforte A; Fontas E; Law MG; Friis-Moller N; Phillips A, 2008, 'Incidence and risk factors for new-onset diabetes, in HIV-infected patients - The data collection on adverse events of Anti-HIV drugs (D : A : D) study', Diabetes Care, 31, pp. 1224 - 1229, http://dx.doi.org/10.2337/dc07-2013

Herzmann C; Cuthbertson Z; Fosdick L; Fisher M; Nelson M; Perry NB; Law MG; Wand HC; Janossy G; Johnson MA; Youle M, 2008, 'Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients', Journal of Antimicrobial Chemotherapy, 62, pp. 583 - 586, http://dx.doi.org/10.1093/jac/dkn238

Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, 197, pp. 1133 - 1144, http://dx.doi.org/10.1086/586713

Wilson DP; Law MG; Grulich AE; Cooper DA; Kaldor JM, 2008, 'Relation between HIV viral load and infectiousness: a model-based analysis', Lancet, 372, pp. 314 - 320

Chih S; Macdonald P; Fenely M; Law M; Graham R; McCrohon J, 2008, 'Reproducibility of Adenosine Stress Cardiac Magnetic Resonance Imaging by Normalised Upslope Analysis in Patients with Severe Coronary Artery Disease', Heart, Lung and Circulation, 17, pp. S47 - S48, http://dx.doi.org/10.1016/j.hlc.2008.05.109

Falster KA; Gelgor L; Shaik A; Zablotska Manos I; Prestage G; Grierson J; Thorpe R; Pitts M; Anderson JS; Chuah J; Mulhall BP; Petoumenos K; Kelleher AD; Law MG, 2008, 'Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment', Sexual Health, 5, pp. 141 - 154

Hoare A; Wilson DP; Regan DG; Kaldor JM; Law MG, 2008, 'Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections', Sexual Health, 5, pp. 169 - 187, http://dx.doi.org/10.1071/SH07099

Amin J; Law MG, 2007, 'Causes of death in hepatitis B and C: a methodological issue', Lancet, 370, pp. 1033, http://dx.doi.org/10.1016/S0140-6736(07)61473-1

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02

Haylen BT; Chetty N; Logan V; Schulz S; Verity L; Law M; Zhou J, 2007, 'Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?', International Urogynecology Journal and Pelvic Floor Dysfunction, 18, pp. 123 - 128, http://dx.doi.org/10.1007/s00192-006-0165-z

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (vol 30, pg 113, 2007)', DIABETES CARE, 30, pp. 455 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244024100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nakhaee FH; McDonald AM; Black DA; Law MG, 2007, 'A feasible method for linkage studies avoiding clerical review: linkage of the national HIV/AIDS surveillance databases with the National Death Index in Australia', Australian and New Zealand Journal of Public Health, 31, pp. 308 - 312

Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, 21, pp. 2315 - 2321

Back to profile page